Bank of Montreal
ADMA icon

Bank of Montreal’s ADMA Biologics ADMA Stock Holding History

Bank of Montreal’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
18,421
+1,850
+11% +$16.9K ﹤0.01% 3106
2026
Q1 		$149K Buy
16,571
+1,521
+10% +$24K ﹤0.01% 3025
2025
Q4 		$275K Sell
15,050
-1,280
-8% -$21.6K ﹤0.01% 2649
2025
Q3 		$239K Sell
16,330
-25,939
-61% -$445K ﹤0.01% 2667
2025
Q2 		$770K Buy
42,269
+6,466
+18% +$132K ﹤0.01% 2039
2025
Q1 		$710K Buy
35,803
+9,241
+35% +$160K ﹤0.01% 1979
2024
Q4 		$456K Sell
26,562
-2,059,760
-99% -$38.8M ﹤0.01% 2284
2024
Q3 		$40.4M Buy
2,086,322
+489,320
+31% +$7.61M 0.02% 541
2024
Q2 		$17.9M Buy
+1,597,002
New +$13.4M 0.01% 807
2022
Q2 		– Sell
-910,000
Closed -$1.67M – 4048
2022
Q1 		$1.67M Buy
+910,000
New +$1.42M ﹤0.01% 2042
2021
Q2 		– Sell
-2,009
Closed -$4K – 3640
2021
Q1 		$4K Sell
2,009
-8,329
-81% -$19.1K ﹤0.01% 4693
2020
Q4 		$22K Buy
10,338
+7,548
+271% +$15.9K ﹤0.01% 4370
2020
Q3 		$7K Sell
2,790
-156,031
-98% -$428K ﹤0.01% 4262
2020
Q2 		$455K Buy
158,821
+11,018
+7% +$31.7K ﹤0.01% 2305
2020
Q1 		$383K Buy
147,803
+3,666
+3% +$12.7K ﹤0.01% 2096
2019
Q4 		$576K Buy
144,137
+139,722
+3,165% +$609K ﹤0.01% 2585
2019
Q3 		$20K Buy
4,415
+2,085
+89% +$8.71K ﹤0.01% 4084
2019
Q2 		$9K Buy
2,330
+2,318
+19,317% +$10.2K ﹤0.01% 4548
2019
Q1 		$0 Sell
12
-267
-96% -$944 ﹤0.01% 4269
2018
Q4 		$1K Buy
279
+145
+108% +$718 ﹤0.01% 4499
2018
Q3 		$1K Hold
134
– – ﹤0.01% 4477
2018
Q2 		$1K Buy
+134
New +$668 ﹤0.01% 4484

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of Montreal's ADMA Position: Q2 2026 in Review

Bank of Montreal increased its ADMA Biologics (ADMA) stake by 11% in Q2 2026, buying an estimated $16.9K and bringing the position to 18,421 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Bank of Montreal first reported a position in ADMA in Q2 2018 and has held it in 22 quarters since. The position peaked at $40.4M in Q3 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Bank of Montreal held 18,421 shares of ADMA Biologics worth $154K as of Q2 2026.
  • Bank of Montreal bought 1,850 ADMA Biologics shares in Q2 2026, an estimated $16.9K.
  • ADMA Biologics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3106 holding.
  • Bank of Montreal first reported a position in ADMA Biologics in Q2 2018 and has held it in 22 quarters since.
  • Bank of Montreal's ADMA Biologics position peaked at $40.4M in Q3 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.